VR101

About J3 Bioscience

J3 Bioscience is a private, clinical-stage biotech leveraging a proprietary vaginal ring delivery system for women's health indications. Its lead product, LivRing, was initially available direct-to-consumer but is now being transitioned to a partner for broader distribution, indicating a shift in commercial strategy. The company is actively exploring new applications for its platform, including a collaboration to study its technology (VR101) for cancer-therapy-related vaginal dryness, moving beyond its initial focus. J3 appears to be in a pivotal stage, refining its business model from a direct product company to a technology developer and licensor.

Therapeutic Areas